Home About Us Pipeline News Investors Contacts Careers




Puma Biotechnology, Inc. Corporate Fact Sheet


RECENT NEWSCURRENT EVENTSCLINICAL TRIALS



February 14, 2017 - Puma Biotechnology to Present at RBC Capital Markets Healthcare Conference
Read

February 8, 2017 - Puma Biotechnology to Present at LEERINK Partners Global Healthcare Conference
Read

January 6, 2017 - Puma Biotechnology Expands Cohort in Phase II SUMMIT Trial of PB272 in HER2 Mutation-Positive Cancer Patients
Read

January 3, 2017 - Puma Biotechnology to Present at J.P. Morgan Healthcare Conference
Read

December 19, 2016 - Puma Biotechnology to Move Stock Exchange Listing to Nasdaq
Ticker symbol to remain PBYI
Read

December 8, 2016 - Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of PB272 in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2016 San Antonio Breast Cancer Symposium
Read

December 7, 2016 - Puma Biotechnology Presents Results of Biomarker Analysis of Phase II Trial of PB272 in Neoadjuvant Treatment of HER2-Positive Locally Advanced Breast Cancer at the 2016 San Antonio Breast Cancer Symposium
Read

December 7, 2016 - Puma Biotechnology Presents Interim Results of Phase II Trial of PB272 for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2016 San Antonio Breast Cancer Symposium
Read

December 6, 2016 - Puma Biotechnology Initiates a Managed Access Program for PB272 (Neratinib) Outside the United States

Caligor Opco LLC to provide regulatory, logistical and supply chain support Read

February 22, 2017 - RBC Capital Markets 2017 Global Healthcare Conference
More

February 8, 2017 - Puma Biotechnology to Present at LEERINK Partners Global Healthcare Conference
More

January 10, 2017 - J.P. Morgan 2017 Healthcare Conference
More

December 6-9, 2016 - Presentations of Investigational Data at the San Antonio Breast Cancer Symposium (SABCS)
More

Puma-Sponsored Trials
Investigator-Sponsored Trials




Annual Report

2015 Annual Report

 Annual Report Archives



Contact

Puma Biotechnology, Inc.
10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024
424-248-6500 Main
424-248-6501 Fax
info@pumabiotechnology.com